COVID-19 mRNA Vaccines and Interstitial Lung Disease Exacerbation: Causation or Just a Temporal Association?
作者信息
Ehteshami-Afshar Solmaz, Raj Rishi
机构信息
Stanford University School of Medicine Stanford, California.
出版信息
Am J Respir Crit Care Med. 2022 Oct 1;206(7):919. doi: 10.1164/rccm.202205-0902LE.
Abstract
摘要
相似文献
1
COVID-19 mRNA Vaccines and Interstitial Lung Disease Exacerbation: Causation or Just a Temporal Association?新冠病毒mRNA疫苗与间质性肺疾病加重：因果关系还是仅仅是时间上的关联？
Am J Respir Crit Care Med. 2022 Oct 1;206(7):919. doi: 10.1164/rccm.202205-0902LE.
2
Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination.病例报告：信使 RNA COVID-19 疫苗接种相关间质性肺炎急性加重。
Int J Infect Dis. 2022 Mar;116:255-257. doi: 10.1016/j.ijid.2022.01.031. Epub 2022 Jan 19.
3
Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.既往感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）会增加接种SARS-CoV-2信使核糖核酸（mRNA）疫苗后的反应原性，并可能根据感染时间延迟疫苗接种。
Infection. 2022 Jun;50(3):791-793. doi: 10.1007/s15010-021-01729-z. Epub 2021 Dec 2.
4
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine.SARS-CoV-2 ARCoV mRNA疫苗的安全性和免疫原性。
Lancet Microbe. 2022 Aug;3(8):e561. doi: 10.1016/S2666-5247(22)00150-1. Epub 2022 May 31.
5
Urticarial vasculitis triggered by SARS-CoV-2 vaccine (mRNA vaccine).由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗（信使核糖核酸疫苗）引发的荨麻疹性血管炎。
J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e743-e744. doi: 10.1111/jdv.18253. Epub 2022 Jun 3.
6
7
COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease.炎症性肠病患者中COVID-19 mRNA疫苗的短期安全性
Gastroenterology. 2022 Mar;162(3):987-988. doi: 10.1053/j.gastro.2021.10.004. Epub 2021 Oct 6.
8
A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients.严格血清阴性肾移植受者中的第四种SARS-CoV-2 mRNA疫苗。
Kidney Int. 2022 Apr;101(4):825-826. doi: 10.1016/j.kint.2022.01.017. Epub 2022 Feb 12.
9
Response to Comment on D'Addio et al. Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes. Diabetes 2022;71:1800-1806.对关于达迪奥等人的评论的回应。1型糖尿病患者队列中SARS-CoV-2 mRNA疫苗的免疫原性和安全性。《糖尿病》2022年；71卷：1800 - 1806页
Diabetes. 2022 Sep 1;71(9):e14. doi: 10.2337/dbi22-0020.
10
Acquired hemophilia A with SARS-CoV-2 mRNA vaccine: first case from Pakistan.新型冠状病毒mRNA疫苗引发的获得性甲型血友病：巴基斯坦首例病例。
Scand J Clin Lab Invest. 2022 Sep;82(5):432-434. doi: 10.1080/00365513.2022.2092902. Epub 2022 Jun 29.
引用本文的文献
1
Interstitial lung disease following COVID-19 vaccination: a disproportionality analysis using the Global Scale Pharmacovigilance Database (VigiBase).新冠病毒疫苗接种后的间质性肺病：利用全球药物警戒数据库（VigiBase）进行的比例失调分析。
BMJ Open Respir Res. 2023 Dec 11;10(1):e001992. doi: 10.1136/bmjresp-2023-001992.
2
COVID-19 in Patients with Chronic Lung Disease.慢性肺病患者中的 COVID-19 。
Clin Chest Med. 2023 Jun;44(2):385-393. doi: 10.1016/j.ccm.2022.11.013. Epub 2022 Nov 22.
本文引用的文献
1
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis.特发性肺纤维化急性加重患者的新冠病毒疫苗接种情况
Am J Respir Crit Care Med. 2022 Jul 15;206(2):219-221. doi: 10.1164/rccm.202112-2765LE.
2
COVID-19 vaccine-associated organizing pneumonia.新型冠状病毒肺炎疫苗相关的机化性肺炎
Respirol Case Rep. 2022 Mar 29;10(5):e0944. doi: 10.1002/rcr2.944. eCollection 2022 May.
3
COVID-19 mRNA vaccine-related interstitial lung disease: Two case reports and literature review.新型冠状病毒肺炎信使核糖核酸疫苗相关间质性肺疾病：两例病例报告及文献综述
Respirol Case Rep. 2022 Mar 23;10(4):e0938. doi: 10.1002/rcr2.938. eCollection 2022 Apr.
4
Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination.病例报告：信使 RNA COVID-19 疫苗接种相关间质性肺炎急性加重。
Int J Infect Dis. 2022 Mar;116:255-257. doi: 10.1016/j.ijid.2022.01.031. Epub 2022 Jan 19.
5
A case of severe interstitial lung disease after COVID-19 vaccination.1例COVID-19疫苗接种后发生的严重间质性肺疾病病例。
QJM. 2022 Jan 5;114(11):805-806. doi: 10.1093/qjmed/hcab263.
Zotero 插件